A comprehensive review highlights the high efficacy of hepatitis A vaccination in preventing infection and controlling outbreaks, with substantial community-wide declines in disease incidence following immunisation programmes.
A new review has found that hepatitis A vaccination offers powerful protection both before and after exposure, while also sharply reducing disease spread in communities that use childhood immunisation programmes.
Researchers in the Czech Republic, writing in eClinicalMedicine, pooled more than four decades of trial and observational data and concluded that a first dose of hepatitis A vaccine prevented about 95.8% of infections when given before exposure. They also found post-exposure vaccination was 96.9% effective, although the certainty behind that estimate was much weaker because much of the evidence came from observational studies.
The review also points to a broader public-health effect. Across 19 studies of national and regional childhood programmes, hepatitis A incidence in children fell by between 80% and 100% after vaccination was introduced. The authors said the strongest gains tended to appear in places where hepatitis A was already widespread, suggesting that baseline disease burden matters more than headline coverage figures alone.
That fits with earlier evidence. A JAMA study of routine vaccination in the United States found hepatitis A rates fell 76% overall between 1990 and 2003, with an 88% drop in states that adopted routine vaccination. The same study also showed a shift in cases towards older adults, reflecting how childhood immunisation can change the age pattern of infection.
The new analysis also reinforces hepatitis A vaccination’s value in outbreak control. A retrospective study from Catalonia found a single post-exposure dose was 97.6% effective, broadly in line with the latest pooled estimate. By contrast, older post-exposure prevention has often relied on immune globulin, which a Cochrane review found could reduce hepatitis A cases but depends on dose and is less convenient than vaccination.
Public-health guidance already points in the same direction. The World Health Organisation recommends incorporating hepatitis A vaccination into national schedules for children aged one year and older, depending on local incidence and cost-effectiveness. The new review adds weight to that approach, while also suggesting that even partial childhood coverage can protect unvaccinated groups by reducing circulation of the virus.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
